SCHEMBL16383149

SCHEMBL16383149

Nc1c(C(=O)O)ccc2cccnc12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.70
LMNA P02545 5/20 0.55
ALOX12 P18054 1/20 0.55
NAPRT Q6XQN6 2/20 0.55
PARP1 P09874 1/20 0.54
KDM4E B2RXH2 5/20 0.52
TDP1 Q9NUW8 2/20 0.52
CYP3A4 P08684 2/20 0.52
MAPT P10636 2/20 0.52
ALOX15 P16050 2/20 0.52
TSHR P16473 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
GMNN O75496 1/20 0.52
TP53 P04637 1/20 0.52
HSP90AA1 P07900 1/20 0.52
MMP2 P08253 1/20 0.52
CYP2D6 P10635 1/20 0.52
MMP9 P14780 1/20 0.52
NFKB1 P19838 1/20 0.52
MMP8 P22894 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11973430 0.84 LMNA (0.56) ALDH1A1LMNAALOX12PARP1KDM4E
SCHEMBL28465492 0.83 ALDH1A1 (0.54) ALDH1A1LMNAALOX12PARP1KDM4E
SCHEMBL69869 0.82 ALDH1A1 (0.70) ALDH1A1LMNAALOX12NAPRTPARP1
SCHEMBL29906219 0.82 ALDH1A1 (0.70) ALDH1A1LMNAALOX12NAPRTPARP1
SCHEMBL1759043 0.82 ALDH1A1 (1.00) ALDH1A1LMNAALOX12KDM4ETP53
SCHEMBL9139640 0.81 ALDH1A1 (0.97) ALDH1A1LMNAALOX12KDM4ETP53
SCHEMBL644794 0.81 ALDH1A1 (0.68) ALDH1A1LMNAALOX12PARP1KDM4E
SCHEMBL999633 0.81 ALDH1A1 (0.68) ALDH1A1LMNAALOX12PARP1KDM4E
SCHEMBL13516424 0.81 ALDH1A1 (0.68) ALDH1A1LMNAALOX12PARP1KDM4E
SCHEMBL8139304 0.80 KDM4E (0.56) ALDH1A1LMNAPARP1KDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017123482-A1 DIHYDROPYRIDO QUINAZOLINE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK SHARP & DOHME CORP. (US) 2017-07-20 WO disclosed
US-9090559-B2 Antiviral compounds HOFFMANN-LA ROCHE INC. (US) 2015-07-28 US disclosed
US-9090559-B2 Antiviral compounds HOFFMANN-LA ROCHE INC. (US) 2015-07-28 US disclosed
US-20150005283-A1 ANTIVIRAL COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2015-01-01 US disclosed
US-20150005283-A1 ANTIVIRAL COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2015-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150005283-A1 ANTIVIRAL COMPOUNDS HAVCR2, EIF2AK2, MAVS ALDH1A1 1653/4885LMNA 3882/4885ALOX12 1671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.